Aug 26, 2023 | ALL NEWS, HemOnc News, HemOnc Research
Congratulations to Dr. Wei Du and her team on their new publication entitled: “LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging”, published recently in the...
Aug 26, 2023 | ALL NEWS, HemOnc News, HemOnc Research
Congratulations to Dr. Benjamin Nacev for receiving the Damon Runyon Clinical Investigator Award for his research focused on “Understanding and targeting chromatin reorganization in ATRX deficient sarcomas”. Dr. Nacev is one of 6 clinical investigators funded...
Jun 15, 2023 | ALL NEWS, HemOnc News, HemOnc Research
The Division of Hem Onc was again strongly represented at this year’s ASCO meeting with many residents, fellows and faculty attending and presenting their recent findings. Congratulations to Dr. Manisha Bhattacharya for receiving the competitive ASCO Young...
Apr 4, 2023 | ALL NEWS, HemOnc News, HemOnc Research
Highlighted Publications Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. In allogeneic hematopoietic stem cell transplantation, donor αβ T cells attack recipient tissues, causing graft-versus-host disease (GVHD),...
Nov 17, 2022 | HemOnc News, HemOnc Research
Highlighted Publications A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease. In this Phase 1 single-center, open-label study of the novel red-cell pyruvate kinase (PKR) activator mitapivat (AG-348) for the...